Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.

AUTOR(ES)

Liang, T J

RESUMO

Receptor tyrosine kinases are important in cell signal transduction and proliferation. Abnormal expression of tyrosine kinases often leads to malignant transformation. C-met is a tyrosine kinase receptor and its ligand is hepatocyte growth factor (HGF). HGF/c-met plays diverse role in regulation of cell growth, shape and movement. Constitutively activated met, such as tpr-met, is a potent oncogene in vitro, but its carcinogenic role in vivo remains unclear. Our study demonstrates that expression of tpr-met leads to development of mammary tumors and other malignancies in transgenic mice, and suggests that deregulated met expression may be involved in mammary carcinogenesis.

Documentos Relacionados

• Characterization of the rearranged tpr-met oncogene breakpoint.
• tpr-met Oncogene Product Induces Maturation-Promoting Factor Activation in Xenopus Oocytes
• tpr-met oncogene product induces maturation-producing factor activation in Xenopus oocytes.
• Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.
• The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions.